PSNL

Personalis (PSNL)

Personalis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PSNL

<< 이전 1 2 3 4 5 6 7 8 9 10 11 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/12/22	07:15	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PSNL	Personalis Inc
2023/12/22	07:12	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PSNL	Personalis Inc
2023/12/20	08:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2023/12/20	08:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2023/12/06	06:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2023/12/06	06:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PSNL	Personalis Inc
2023/12/04	23:15	Business Wire	Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives	NASDAQ:PSNL	Personalis Inc
2023/12/02	06:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2023/11/29	06:58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2023/11/29	06:15	Business Wire	Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing	NASDAQ:PSNL	Personalis Inc
2023/11/21	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2023/11/21	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2023/11/08	06:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PSNL	Personalis Inc
2023/11/08	06:01	Business Wire	Personalis Reports Third Quarter 2023 Financial Results	NASDAQ:PSNL	Personalis Inc
2023/11/08	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2023/10/26	21:15	Business Wire	Personalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in Cancer	NASDAQ:PSNL	Personalis Inc
2023/10/25	05:01	Business Wire	Personalis to Announce Third Quarter 2023 Financial Results	NASDAQ:PSNL	Personalis Inc
2023/10/21	17:25	Business Wire	Analysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD Technology	NASDAQ:PSNL	Personalis Inc
2023/10/19	20:15	Business Wire	Personalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023	NASDAQ:PSNL	Personalis Inc
2023/10/18	20:15	Business Wire	Personalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical Compliance	NASDAQ:PSNL	Personalis Inc
2023/08/30	05:01	Business Wire	Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference	NASDAQ:PSNL	Personalis Inc
2023/08/29	06:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2023/08/25	08:01	Business Wire	Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PSNL	Personalis Inc
2023/08/09	05:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PSNL	Personalis Inc
2023/08/09	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2023/08/09	05:01	Business Wire	Personalis Reports Second Quarter 2023 Financial Results	NASDAQ:PSNL	Personalis Inc
2023/08/03	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2023/08/02	05:01	Business Wire	Personalis to Participate at Upcoming Investor Conferences	NASDAQ:PSNL	Personalis Inc
2023/07/26	05:01	Business Wire	Personalis to Announce Second Quarter 2023 Financial Results	NASDAQ:PSNL	Personalis Inc
2023/06/27	06:00	Business Wire	Personalis Files Second Patent Infringement Suit Against Foresight Diagnostics	NASDAQ:PSNL	Personalis Inc